The Development of Drugs against Acanthamoeba Infections

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2016-09-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AAC.00686-16PMID 27600042PMCID PMC5075048
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting cyst wall is an effective strategy in improving the efficacy of marketed contact lens disinfecting solutions against Acanthamoeba castellanii cysts.

  2016cited by this paper
• Photochemotherapeutic Strategy against Acanthamoeba Infections

  2015influential reference
• An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment

  2015cited by this paper
• Strategies for the prevention of contact lens‐related Acanthamoeba keratitis: a review

  2015cited by this paper
• ACANTHAMOEBA Biology and Pathogenesis (2nd edition)

  2015cited by this paper
• Encystment in Acanthamoeba castellanii: a review.

  2014cited by this paper
• Genome of Acanthamoeba castellanii highlights extensive lateral gene transfer and early evolution of tyrosine kinase signaling

  2013cited by this paper
• [Delayed course of Acanthamoeba keratitis].

  2013cited by this paper
• Protrahierter Verlauf einer Akanthamöbenkeratitis

  2013cited by this paper
• Coinfection with Acanthamoeba and Pseudomonas in Contact Lens–Associated Keratitis

  2013cited by this paper
• Investigational Drug Available Directly from CDC for the Treatment of Infections with Free-Living Amebae

  2013cited by this paper
• In Vitro Efficacies of Clinically Available Drugs against Growth and Viability of an Acanthamoeba castellanii Keratitis Isolate Belonging to the T4 Genotype

  2013cited by this paper
• Central nervous system infection with Acanthamoeba in a malnourished child

  2012cited by this paper
• Treatment of granulomatous amoebic encephalitis with voriconazole and miltefosine in an immunocompetent soldier.

  2012cited by this paper
• Efficacy of miltefosine for topical treatment of Acanthamoeba keratitis in Syrian hamsters

  2012cited by this paper
• Role of voriconazole in combined acanthamoeba and fungal corneal ulcer.

  2011cited by this paper
• Acanthamoeba keratitis due to genotype T11 in a rigid gas permeable contact lens wearer in Spain.

  2011cited by this paper
• Riboflavin and Ultraviolet A Collagen Crosslinking of the Cornea for the Treatment of Keratitis

  2010cited by this paper
• Recent outbreaks of atypical contact lens-related keratitis: what have we learned?

  2010cited by this paper
• Pathogenesis of acanthamoeba keratitis.

  2010cited by this paper
• Acute Granulomatous Acanthamoeba Encephalitis in an Immunocompetent Patient

  2010cited by this paper
• An Atypical Case of Microcysts Associated With Silicone Hydrogel Contact Lens: Findings on In Vivo Confocal Laser Microscopy

  2009cited by this paper
• Amoebicidal Activities of Alexidine Against 3 Pathogenic Strains of Acanthamoeba

  2009cited by this paper
• Bilateral Acanthamoeba Keratitis After Orthokeratology

  2009cited by this paper
• Acanthameba meningitis with successful outcome

  2009cited by this paper
• Medical treatment for combined Fusarium and Acanthamoeba keratitis

  2009cited by this paper
• A Case of Descemet's Membrane Rupture in a Patient Affected by Acanthamoeba Keratitis

  2009cited by this paper
• Effect of free versus liposomal-complexed pentamidine isethionate on biological characteristics of Acanthamoeba castellanii in vitro.

  2009cited by this paper
• Acanthamoeba keratitis in the south of Sweden.

  2009cited by this paper
• First case of granulomatous amebic encephalitis caused by Acanthamoeba castellanii in Taiwan.

  2009cited by this paper
• Bilateral acanthamoeba keratitis after orthokeratology.

  2009cited by this paper
• Acanthamoeba: Biology and Pathogenesis

  2009cited by this paper
• Context‐dependent IL‐6 potentiation of interferon‐ gamma‐induced IL‐12 secretion and CD40 expression in murine microglia

  2009cited by this paper
• Contact lens-related acanthamoeba keratitis.

  2009cited by this paper
• Acanthamoeba infection in a patient with chronic graft‐versus‐host disease occurring during treatment with voriconazole

  2008cited by this paper
• Cure of Acanthamoeba cerebral abscess in a liver transplant patient

  2008cited by this paper
• Successful Treatment of Disseminated Acanthamoeba sp. Infection with Miltefosine

  2008cited by this paper
• Rapid Progression of Amebic Keratitis 1 Week After Corneal Trauma and 1 Year After LASIK

  2007cited by this paper
• Good Visual Outcome After Prompt Treatment of Acanthamoeba Keratitis Associated With Overnight Orthokeratology Lens Wear

  2007cited by this paper
• [Acanthamoeba keratitis: about the first two Tunisian cases].

  2007cited by this paper
• A case of successful treatment of cutaneous Acanthamoeba infection in a lung transplant recipient

  2007cited by this paper
• Bilateral Acanthamoeba Keratitis in an Experienced Two-Weekly Disposable Contact Lens Wearer

  2007cited by this paper
• Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea.

  2007cited by this paper
• Acanthamoeba keratitis related to orthokeratology

  2007cited by this paper
• Effect of caspofungin on trophozoites and cysts of three species of Acanthamoeba.

  2006cited by this paper
• In vitro antiproliferative effects of neuroleptics, antimycotics and antibiotics on the human pathogens Acanthamoeba polyphaga and Naegleria fowleri.

  2006cited by this paper
• Benzethonium Chloride: A Novel Anticancer Agent Identified by Using a Cell-Based Small-Molecule Screen

  2006influential reference
• Acanthamoeba: biology and increasing importance in human health.

  2006cited by this paper
• Acanthamoeba keratitis after LASIK.

  2006cited by this paper
• Case Report: Successful Treatment of Acanthamoeba Rhinosinusitis in a Patient with AIDS

  2005cited by this paper
• Acanthamoeba infection in lung transplantation: report of a case and review of the literature

  2005cited by this paper
• Acanthamoeba infection as a cause of severe keratitis in a soft contact lens wearer in Jamaica.

  2005cited by this paper
• Opportunistic amoebae: challenges in prophylaxis and treatment.

  2004cited by this paper
• Disseminated cutaneous acanthamebiasis: a case report and review of the literature.

  2004cited by this paper
• A novel combination treatment of chlorhexidine gluconate, natamycin (pimaricin) and debridement for a Acanthamoeba keratitis.

  2003cited by this paper
• Acanthamoeba spp. as Agents of Disease in Humans

  2003cited by this paper
• Bilateral Acanthamoeba Keratitis with Late Recurrence of the Infection in a Corneal Graft: A Case Report

  2003cited by this paper
• Acanthamoeba keratitis as a complication of orthokeratology.

  2003cited by this paper
• [Acanthamoeba keratitis after use of soft contact lenses--case report].

  2003cited by this paper
• Acanthameba meningoencephalitis: a case report.

  2002cited by this paper
• Acanthamoeba keratitis presenting as dendritic keratitis in a soft contact lens wearer.

  2002cited by this paper
• Cytotoxic Activities of Alkylphosphocholines against Clinical Isolates of Acanthamoeba spp

  2002cited by this paper
• Nekrotisierende ulzerierende Keratopathie nach Lokalanästhetikamissbrauch

  2002cited by this paper
• [A clinico-pathological case report of necrotizing ulcerating keratopathy due to topical anaesthetic abuse].

  2002cited by this paper
• Successful treatment of Acanthamoeba meningitis with combination oral antimicrobials.

  2001influential reference
• Granulomatous Amebic Encephalitis in a Patient with AIDS: Isolation of Acanthamoeba sp. Group II from Brain Tissue and Successful Treatment with Sulfadiazine and Fluconazole

  2000cited by this paper
• The Increasing Importance of Acanthamoeba Infections1

  2000cited by this paper
• Treatment of Acanthamoeba keratitis combined with fungal infection with polyhexamethylene biguanide.

  1999cited by this paper
• The pathogenesis of Acanthamoeba keratitis.

  1999cited by this paper
• Treatment of acanthamoeba keratitis with chlorhexidine.

  1999cited by this paper
• Acanthamoeba keratitis with symbiosis of Hartmannella ameba.

  1998cited by this paper
• Acanthamoeba keratitis in New Zealand, including two cases with in vivo resistance to polyhexamethylene biguanide.

  1998cited by this paper
• [Acanthamoeba keratitis].

  1996cited by this paper
• Successful medical therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine

  1996cited by this paper
• Cytologic diagnosis of Acanthamoeba keratitis. Report of a case with correlative study with indirect immunofluorescence and scanning electron microscopy.

  1995cited by this paper
• [A case of Acanthamoeba keratitis after operation for cataract].

  1995cited by this paper
• Successful treatment of Acanthamoeba keratitis by hexamidine.

  1994cited by this paper
• Brief report: successful treatment of disseminated acanthamoeba infection in an immunocompromised patient.

  1994cited by this paper
• Drug resistance and Acanthamoeba Keratitis: The quest for alternative antiprotozoal chemotherapy

  1994cited by this paper
• Acanthamoeba keratitis: a sobering case and a promising new treatment.

  1994cited by this paper
• [Two cases of early Acanthamoeba keratitis].

  1993cited by this paper
• Combined treatment of Acanthamoeba keratitis with propamidine, neomycin, and polyhexamethylene biguanide.

  1993cited by this paper
• Polyhexamethylene biguanide in the treatment of Acanthamoeba keratitis.

  1993cited by this paper
• Acanthamoeba keratitis.

  1992cited by this paper
• Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide.

  1992cited by this paper
• Successful medical management of Acanthamoeba keratitis.

  1991cited by this paper
• Successful medical management of Acanthamoeba keratitis.

  1990cited by this paper
• Acanthamoeba keratitis with two species of Acanthamoeba.

  1990cited by this paper
• Acanthamoeba keratitis successfully treated with prolonged propamidine isethionate and neomycin-polymyxin-gramicidin.

  1990cited by this paper
• Oral itraconazole and topical miconazole with débridement for Acanthamoeba keratitis.

  1990cited by this paper
• Acanthamoeba keratitis associated with contact lenses: six consecutive cases of successful management.

  1989cited by this paper
• Acanthamoeba Keratitis: Potential Role for Topical Clotrimazole in Combination Chemotherapy

  1988cited by this paper
• Acanthamoebic keratitis diagnosed by paracentesis and biopsy and treated with propamidine.

  1987cited by this paper
• Granulomatous brain tumor caused by Acanthamoeba. Case report.

  1986cited by this paper
• Acanthamoeba keratitis successfully treated medically.

  1985cited by this paper
• Acanthamoeba keratitis associated with soft contact lenses.

  1985cited by this paper
• A case of keratitis due to Acanthamoeba in New York, New York, and features of 10 cases.

  1981cited by this paper
• Chemotherapeutic compounds and Acanthamoebae from eye infections.

  1976cited by this paper
• Sensitivity of Hartmannella (Acanthamoeba) to 5-fluorocytosine, hydroxystilbamidine, and other substances

  1970cited by this paper

• Genomic Landscape Reveals Correlation of Endosymbiont Ralstonia With Acanthamoeba Keratitis Severity

  2026cites this paper
• Efficacy of phosphonium amphiphilic salts against Acanthamoeba genotype T4

  2026cites this paper
• Effect of aqueous extract of Eucalyptus Microtheca on Acanthamoeba genotype T5, an in vitro study

  2025cites this paper
• Encystment and Excystment Processes in Acanthamoeba castellanii: An Emphasis on Cellulose Involvement

  2025cites this paper
• Morphological and Chemical Changes in the Trophozoites and Cysts of Acanthamoeba Castellanii Induced by Camellia Sinensis Extracts

  2025cites this paper
• Enhancing Acanthamoeba diagnostics: rapid detection of viable Acanthamoeba trophozoites and cysts using viability PCR assay

  2025cites this paper
• Amebicidal and Antiadhesion Activities of Knema retusa Extract Against Acanthamoeba triangularis T4 Genotype on Contact Lenses and Modeling Simulation of Its Main Compound, E2N, Against Acanthamoeba Beta-Tubulin

  2025cites this paper
• Integrating molecular pathogenesis and predictive modelling in granulomatous amoebic encephalitis due to Acanthamoeba: a digital twin framework for personalised therapy

  2025cites this paper
• Inhibition of GABA metabolism by β-lactam antibiotics affects encystation in Acanthamoeba.

  2025cites this paper
• The pathogenesis, risk factors, diagnosis and treatment of Acanthamoeba keratitis

  2025cites this paper
• Inhibitory and anti-adherent effects of Piper betle L. leaf extract against Acanthamoeba triangularis in co-infection with Staphylococcus aureus and Pseudomonas aeruginosa: A sustainable one-health approach

  2024cites this paper
• Efficacy of propolis extract and eye drop solutions to suppress encystation and excystation of Acanthamoeba triangularis WU19001-T4 genotype

  2024cites this paper
• Chitosan nanoparticles improve the effectivity of miltefosine against Acanthamoeba

  2024cites this paper
• Acanthamoeba Keratitis in China: Genotypic and Clinical Correlations

  2024cites this paper
• Clinical outcomes and prognostic factors in Acanthamoeba keratitis.

  2024cites this paper
• Anti-adherent effects of Rhizophora apiculata bark and leaf extracts and computational prediction of the effects of its compound on β-tubulin interaction in Acanthamoeba triangularis genotype 4

  2024cites this paper
• Drug modifications: graphene oxide-chitosan loading enhanced anti-amoebic effects of pentamidine and doxycycline

  2024cites this paper
• Plants of the family Lamiaceae as a source of therapeutic agents against Acanthamoeba infections

  2024cites this paper
• Comparative genomic analysis of Acanthamoeba from different sources and horizontal transfer events of antimicrobial resistance genes

  2024cites this paper
• Metal Oxide Nanoparticles Exhibit Anti-Acanthamoeba castellanii Properties by Inducing Necrotic Cell Death

  2024cites this paper
• Acanthamoeba keratitis: new hopes for potential interventions for a curable but often refractory disease

  2024influential citation
• Assessing PCR-Positive Acanthamoeba Keratitis—A Retrospective Chart Review

  2024cites this paper
• Phosphonium chloride–based deep eutectic solvents inhibit pathogenic Acanthamoeba castellanii belonging to the T4 genotype

  2024cites this paper
• Characterization of novel extracellular proteases produced by Acanthamoeba castellanii after contact with human corneal epithelial cells and their relevance to pathogenesis

  2024cites this paper
• Caffeic Acid Phosphanium Derivatives: Potential Selective Antitumor, Antimicrobial and Antiprotozoal Agents

  2024cites this paper
• Preparation and evaluation of a niosomal delivery system containing G. mangostana extract and study of its anti-Acanthamoeba activity

  2024influential citation
• Glucose metabolism in the pathogenic free‐living amoebae: Tempting targets for treatment development

  2023cites this paper
• Effects of In Vitro Combination of Nitric Oxide Donors and Hypochlorite on Acanthamoeba castellanii Viability

  2023cites this paper
• Comparing Cytotoxicity and Efficacy of Miltefosine and Standard Antimicrobial Agents Against Acanthamoeba Trophozoites and Cyst Forms: An In Vitro Study.

  2023cites this paper
• Synthesis, anti-amoebic activity and molecular docking simulation of eugenol derivatives against Acanthamoeba sp.

  2023cites this paper
• Novel Anti-Acanthamoebic Activities of Irosustat and STX140 and Their Nanoformulations

  2023cites this paper
• Anti-Acanthamoeba Potential of Valproate Sodium; an In Vitro Study

  2023influential citation
• Cell death of Acanthamoeba castellanii following exposure to antimicrobial agents commonly included in contact lens disinfecting solutions

  2023influential citation
• Recognition of Cell Wall Mannosylated Components as a Conserved Feature for Fungal Entrance, Adaptation and Survival Within Trophozoites of Acanthamoeba castellanii and Murine Macrophages

  2022cites this paper
• Amoebicidal Activity of Poly-Epsilon-Lysine Functionalized Hydrogels

  2022cites this paper
• Development of a Machine Learning-Based Cysticidal Assay and Identification of an Amebicidal and Cysticidal Marine Microbial Metabolite against Acanthamoeba

  2022cites this paper
• Potential anti-acanthamoebic effects through inhibition of CYP51 by novel quinazolinones.

  2022cites this paper
• Camellia sinensis solvent extract, epigallocatechin gallate and caffeine confer trophocidal and cysticidal effects against Acanthamoeba castellanii.

  2022cites this paper
• Homology Modeling, Molecular Docking, Molecular Dynamic Simulation, and Drug-Likeness of the Modified Alpha-Mangostin against the β-Tubulin Protein of Acanthamoeba Keratitis

  2022cites this paper
• Camellia sinensis solvent extract confers trophocidal and cysticidal effects against Acanthamoeba castellanii

  2022influential citation
• Amoebicidal activity of cationic carbosilane dendrons derived with 4-phenylbutyric acid against Acanthamoeba griffini and Acanthamoeba polyphaga trophozoites and cysts

  2022cites this paper
• Antiamoebic Activity of Imidazothiazole Derivatives against Opportunistic Pathogen Acanthamoeba castellanii

  2022cites this paper
• Development of anti-acanthamoebic approaches

  2021cites this paper
• Derivatisation of metronidazole enhances cytotoxic effect against Acanthamoeba genotype T4 isolates and leads to cytomorphological changes in trophozoites.

  2021cites this paper
• Two Ecdysteroids Isolated from Micropropagated Lychnis flos-cuculi and the Biological Activity of Plant Material

  2021cites this paper
• In vitro validation of the amoebicidal activity of commercial eye drops as second activity

  2021cites this paper
• Anti-Acanthamoeba synergistic effect of chlorhexidine and Garcinia mangostana extract or α-mangostin against Acanthamoeba triangularis trophozoite and cyst forms

  2021cites this paper
• Acanthamoeba Keratitis: an update on amebicidal and cysticidal drug screening methodologies and potential treatment with azole drugs

  2021influential citation
• Practical Guidance for Clinical Microbiology Laboratories: Diagnosis of Ocular Infections

  2021cites this paper
• Applications of medicinal chemistry for drug discovery against Acanthamoeba infections

  2021cites this paper
• Evaluation of in vitro activity of five antimicrobial agents on Acanthamoeba isolates and their toxicity on human corneal epithelium

  2021influential citation
• Evaluation of Amebicidal and Cysticidal Activities of Antifungal Drug Isavuconazonium Sulfate against Acanthamoeba T4 Strains

  2021cites this paper
• Evaluating Potential of Electromagnetic Microwaves on Destruction Acanthamoeba Cysts

  2020cites this paper
• Synergistic Effect of Garcinia Mangostana Combined With Chlorhexidine on Acanthamoeba Triangularis Trophozoites and Cysts

  2020cites this paper
• In Vitro Growth- and Encystation-Inhibitory Efficacies of Matcha Green Tea and Epigallocatechin Gallate Against Acanthameoba Castellanii

  2020cites this paper
• Antimicrobial resistance of ocular microbes and the role of antimicrobial peptides

  2020cites this paper
• Current strategies to treat Acanthamoeba keratitis: a patent overview.

  2020cites this paper
• Diagnostics and management approaches for Acanthamoeba keratitis

  2020cites this paper
• Anti-amoebic potential of azole scaffolds and nanoparticles against pathogenic Acanthamoeba.

  2020cites this paper
• In vitro activity of Camellia sinensis (green tea) against trophozoites and cysts of Acanthamoeba castellanii

  2020cites this paper
• Antiamoebic activity of 3-aryl-6,7-dimethoxyquinazolin-4(3H)-one library against Acanthamoeba castellanii

  2020cites this paper
• Drug Discovery against Acanthamoeba Infections: Present Knowledge and Unmet Needs

  2020cites this paper
• Parasitic keratitis – An under-reported entity

  2020cites this paper
• Discovery of Anti-Amoebic Inhibitors from Screening the MMV Pandemic Response Box on Balamuthia mandrillaris, Naegleria fowleri, and Acanthamoeba castellanii

  2020cites this paper
• Discovery of repurposing drug candidates for the treatment of diseases caused by pathogenic free-living amoebae

  2020cites this paper
• Alkyl-carbon chain length of two distinct compounds and derivatives are key determinants of their anti-Acanthamoeba activities

  2020cites this paper
• Topical Voriconazole as Supplemental Treatment for Acanthamoeba Keratitis.

  2020cites this paper
• In vitro activity of isavuconazole against three species of Acanthamoeba.

  2020cites this paper
• Viability test exclusively is not adequate to evaluate the T4 Acanthamoeba keratitis’ treatment

  2020cites this paper
• The Antifungal Drug Isavuconazole Is both Amebicidal and Cysticidal against Acanthamoeba castellanii

  2020cites this paper
• Repurposing of drugs is a viable approach to develop therapeutic strategies against central nervous system-related pathogenic amoebae.

  2020cites this paper
• In Vitro Amoebicidal Activity of Imidazolium Salts Against Trophozoites

  2020cites this paper
• In vitro amoebicidal effect of Aloe vera ethanol extract and honey against Acanthamoeba spp. cysts

  2020cites this paper
• Acanthamoeba keratitis: a review of biology, pathophysiology and epidemiology

  2020cites this paper
• Discovery of Amoebicidal Compounds by Combining Computational and Experimental Approaches

  2020cites this paper
• The Effect of Anti-Amoebic Agents and Ce6-PDT on Acanthamoeba castellanii Trophozoites and Cysts, In Vitro

  2020cites this paper
• Evaluation of the sensitivity to chlorhexidine, voriconazole and itraconazole of T4 genotype Acanthamoeba isolated from Mexico.

  2019cites this paper
• Repositioning of guanabenz in conjugation with gold and silver nanoparticles against pathogenic amoebae Acanthamoeba castellanii and Naegleria fowleri.

  2019cites this paper
• Evaluating the in vitro efficacy of gatifloxacin, levofloxacin and gentamicin against Acanthamoeba cysts

  2019cites this paper
• Acanthamoeba in Southeast Asia – Overview and Challenges

  2019cites this paper
• Novel antiacanthamoebic compounds belonging to quinazolinones.

  2019cites this paper
• Synthetic Dihydropyridines as Novel Antiacanthamoebic Agents.

  2019cites this paper
• Cobalt nanoparticles as novel nanotherapeutics against Acanthamoeba castellanii

  2019cites this paper
• Oleic acid–conjugated silver nanoparticles as efficient antiamoebic agent against Acanthamoeba castellanii

  2019cites this paper
• Riboflavin-UVA collagen cross-linking for the treatment of acanthamoeba keratitis

  2019cites this paper
• Answer to Photo Quiz: Disseminated Acanthamoeba Infection

  2019cites this paper
• Antimicrobial activities of green synthesized gums-stabilized nanoparticles loaded with flavonoids

  2019cites this paper
• Safety of intrastromal injection of polyhexamethylene biguanide and propamidine isethionate in a rabbit model

  2019cites this paper
• Anti-parasitic drug discovery takes a giant leap forward1

  2019cites this paper
• Answer to May 2019 Photo Quiz

  2019cites this paper
• Comparison of in vitro assays to study the effectiveness of antiparasitics against Acanthamoeba castellani trophozoites and cysts.

  2019cites this paper
• Acanthamoeba Mannose-Binding Protein: Structural and functional characterisation of a therapeutic target for Acanthamoeba keratitis

  2018cites this paper
• In Vitro Amoebicidal Activity of Titanium Dioxide/UV-A Combination Against Acanthamoeba.

  2018cites this paper
• Contact Lenses and Infectious Keratitis

  2018cites this paper
• Effect of Nitric Oxide on Acanthamoeba castellanii.

  2018cites this paper
• Anti-Acanthamoeba Activity of Brominated Sesquiterpenes from Laurencia johnstonii

  2018cites this paper
• Extracellular vesicles and vesicle-free secretome of the protozoa Acanthamoeba castellanii under homeostasis and nutritional stress and their damaging potential to host cells

  2018cites this paper
• Screening for in vitro amoebicidal activity of plant essential oils against Acanthamoeba sp.

  2018cites this paper
• Clinically Approved Drugs against CNS Diseases as Potential Therapeutic Agents To Target Brain-Eating Amoebae.

  2018cites this paper
• Combating Acanthamoeba spp. cysts: what are the options?

  2018cites this paper